Wu, X.-Y.; Lee, Y.-K.; Lau, Y.-M.; Au, K.-W.; Tse, Y.-L.; Ng, K.-M.; Wong, C.-K.; Tse, H.-F.
The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals 2024, 17, 1030.
https://doi.org/10.3390/ph17081030
AMA Style
Wu X-Y, Lee Y-K, Lau Y-M, Au K-W, Tse Y-L, Ng K-M, Wong C-K, Tse H-F.
The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals. 2024; 17(8):1030.
https://doi.org/10.3390/ph17081030
Chicago/Turabian Style
Wu, Xin-Yi, Yee-Ki Lee, Yee-Man Lau, Ka-Wing Au, Yiu-Lam Tse, Kwong-Man Ng, Chun-Ka Wong, and Hung-Fat Tse.
2024. "The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models" Pharmaceuticals 17, no. 8: 1030.
https://doi.org/10.3390/ph17081030
APA Style
Wu, X.-Y., Lee, Y.-K., Lau, Y.-M., Au, K.-W., Tse, Y.-L., Ng, K.-M., Wong, C.-K., & Tse, H.-F.
(2024). The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models. Pharmaceuticals, 17(8), 1030.
https://doi.org/10.3390/ph17081030